Check out FDAs new roster of bulk drug substances being pulled from use in compounding. Youll see BPC 157 and TB 500 among the various peptides added to the list of category 2 substances Excellent news for us on the frontiers of medicine. Bringing back peptides to compounding pharmacies is the long awaited expectation from this administration. I voted for this. In September 2023, the Biden The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions Peptide Injections: Are They Safe?